Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria - Wikidata - wikimedia - TriplyDB

Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria

Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria

http://www.wikidata.org/entity/Q38148750

about

Dipeptidyl peptidase-4 and kidney fibrosis in diabetes Teneligliptin in Management of Diabetic Kidney Disease: A Review of Place in Therapy.How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy Novel effective drugs for diabetic kidney disease? or not?Novel avenues for treating diabetic nephropathy: new investigational drugs.Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of diabetic nephropathy in Chinese patients with newly diagnosed type 2 diabetes: A cross-sectional study.One-year treatment with liraglutide improved renal function in patients with type 2 diabetes: a pilot prospective study.Pituitary adenylate cyclase-activating polypeptide protects glomerular podocytes from inflammatory injuries.Combination of Vildagliptin and Pioglitazone in Experimental Type 2 Diabetes in Male Rats.Effect of Linagliptin on Structural Changes in the Kidney in Experimental Type 2 Diabetes Mellitus.Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes

P2860

Q26766089-FE3EC920-53E7-4189-8B2C-4BE1F6B10E72 Q30399639-09DF0018-33FA-4D75-9FAA-7AF5AA29004D Q33779315-4BCFDAB0-B7EC-4EBD-B16B-A8B48E6D01D9 Q36220047-B0772262-435E-45DB-B6DD-9EE0A175C351 Q38265818-1F3B415B-E96A-4B79-8AD2-251C31FF161F Q39170387-29CDDC44-3BF5-4139-8359-2EE8F91B9B18 Q40944394-8805D709-20C8-4FAC-8BE7-73FA8ACF1CD7 Q41604037-6EB17E95-B1C2-47BE-9DFA-D812B4B6C7C3 Q43191371-A62A7FB7-3C9A-4CEE-B9D9-297A9FB6C63E Q46475564-21E611E3-07A4-4499-A48F-26F2D587FA71 Q48683668-1C35715D-4DFA-4DFF-AA61-DE6B62945DE4 Q57477167-48357B9B-D145-4C80-B8BE-82ABD978A207

P2860

Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria

http://www.wikidata.org/entity/Q38148750

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria

@en

type

label

Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria

@en

prefLabel

Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria

@en

P1433

Q38148750-B643F433-3E8D-4062-A75F-AF59D2A3E16C

P1476

Q38148750-7DD4AC8E-0623-4AA5-B22F-5EDE56A5F46B

P2093

Q38148750-DA269290-848A-4788-A982-5E87524A92CD

P2860

Q38148750-0F945FDD-9805-4D72-BCA8-57EE0B927AA6

Q38148750-10F461A3-E441-42B5-B690-38B366DD235A

Q38148750-146DBA97-3CBA-4DE1-ACB5-E393BFD085BD

Q38148750-17A9220D-94D0-4E22-98D5-CDF785524BF9

Q38148750-1C1905F3-1D97-4B15-945D-1BDDA0EB8942

Q38148750-1E09F50D-561D-47EB-9AA9-7DE41E70E442

Q38148750-23E0EECC-7A55-4FD0-835C-84996F025D6A

Q38148750-246E8D81-9F46-44E1-84A3-9A6B37FC3F4C

Q38148750-2904B006-6BE8-4865-823F-690B3EFC7C03

Q38148750-2D02F094-BAD1-4DE3-AC8C-2AF9A5B37566

P304

Q38148750-0B687929-CFF1-42B2-BA46-2D5CFDFB5D92

P31

Q38148750-8B007C97-F5FB-4EE7-8870-8C74BDE24781

P356

Q38148750-E3A49793-E802-4E7E-A0B7-530AE1D991DF

P478

Q38148750-DC1DEB14-663D-4780-9C05-5F8513B5E4E0

P50

Q38148750-3CE00412-82D0-48B5-B1F8-9FDF1BC6A9F7

Q38148750-86E72B06-9954-4F65-ADC2-DAC74743E40E

P577

Q38148750-18AC9ACA-1340-4169-A5A0-093DD568D86C

P5875

Q38148750-41F174AF-84B9-428B-BB9D-82F01D213D41

P698

Q38148750-68010660-081C-4BCC-BC15-DB449D228B67

P932

Q38148750-D3B9D8C6-BBEE-4E51-83A8-3BB1CDD65509

P356

P1433

International journal of endocrinology

P1476

Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria

@en

P2093

Jan Frolík

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Disease-dependent mechanisms of albuminuria.

Model of albumin reabsorption in the proximal tubule.

TGF-beta signaling in renal disease.

Cell biology of the glomerular podocyte.

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.

Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat).

Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells.

Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetes

P304

895102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/895102

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Martin Haluzík

P577

2013-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257310724

http://www.w3.org/2001/XMLSchema#string

P698

24089613

http://www.w3.org/2001/XMLSchema#string

P932

3780627

http://www.w3.org/2001/XMLSchema#string